Oxford Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Oxford Asset Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28,435	Closed	-$80K	–	1682
2019 Q4	$80K	Sell	28,435 -1,871	-6%	-$6K	﹤0.01%	1638
2019 Q3	$161K	Sell	30,306 -2,176	-7%	-$14.5K	﹤0.01%	1598
2019 Q2	$312K	Buy	32,482 +5,239	+19%	+$96.4K	0.01%	1435
2019 Q1	$730K	Sell	27,243 -1,990	-7%	-$50.6K	0.02%	1074
2018 Q4	$661K	Buy	29,233 +21,474	+277%	+$840K	0.02%	1073
2018 Q3	$433K	Buy	+7,759	New	+$495K	0.01%	1360
2017 Q2	–	Sell	-2,018	Closed	-$371K	–	1788
2017 Q1	$371K	Buy	2,018 +903	+81%	+$101K	0.01%	1145
2016 Q4	$90K	Buy	+1,115	New	+$88.2K	﹤0.01%	736
2016 Q1	–	Sell	-4,133	Closed	-$836K	–	952
2015 Q4	$836K	Buy	+4,133	New	+$825K	0.02%	577

Other funds holding TTPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Oxford Asset Management's TTPH Position: Q1 2020 in Review

Oxford Asset Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2020, closing a stake of 28,435 shares — an estimated $80K sold.

Oxford Asset Management first reported a position in TTPH in Q4 2015 and held it in 9 quarters. The position peaked at $836K in Q4 2015. 25 funds tracked by Wall St. Rank hold TTPH as of Q1 2020.

Oxford Asset Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 28,435 Tetraphase Pharmaceuticals, Inc. shares in Q1 2020, an estimated $80K.
Oxford Asset Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2015 and held it in 9 quarters.
Oxford Asset Management's Tetraphase Pharmaceuticals, Inc. position peaked at $836K in Q4 2015.
25 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.